• The Company
    • Who we are
    • Partner Portal
  • Meet the Partners
  • Our Approach
  • Portfolio
    • Current Portfolio
    • Historic Portfolio
  • News
  • Contact Us
The Vertical Group
Investing for Innovation

TetraLogic Pharmaceuticals Announces New Executives 

8/19/2013

 
Via TetraLogic:
MALVERN, Pa., August 19, 2013 – TetraLogic Pharmaceuticals, a biopharmaceutical company 
developing novel small molecule SMAC mimetic drugs to treat cancer, today announced the appointment 
of a new senior executive leadership team with the goal of accelerating the development of the company 
and its lead product candidate birinapant. The new TetraLogic senior executives are J. Kevin Buchi, 
President and Chief Executive Officer, Pete A. Meyers, Chief Financial Officer, and Lesley Russell, 
MBChB, MRCP, Chief Operating Officer. John M. Gill, the departing President, Chief Executive Officer 
and Co-founder of TetraLogic, will continue to serve on the company’s Board of Directors. 
 
“I am pleased to hand over the reins to Kevin who is a highly regarded leader within our industry,” stated 
Mr. Gill. “Together with Pete Meyers and Lesley Russell, this team represents the ideal complement to 
the existing team at TetraLogic, bringing the expertise and experience we need to maximize the value of 
our lead SMAC mimetic drug candidate birinapant, grow the company, and realize the full economic 
potential of our commercial opportunities for our shareholders.” 
 
“I am honored to be chosen to lead TetraLogic at this very exciting time for the company,” stated Mr. 
Buchi. “With a strong team and clear leadership position in SMAC mimetics, we have a tremendous 
opportunity to continue the momentum established for birinapant as a potential treatment for both solid 
tumors and hematological malignancies. Having spent most of my career in the biotech industry, I have a 
strong sense of the opportunities for success at TetraLogic and look forward to leading the company into 
what promises to be an exciting future.” 

Read more: http://files.shareholder.com/downloads/AMDA-2C8MW4/2989657472x0x707407/d77fd66f-c0e6-4b0a-9cd9-fd8eb1602e6b/707407.pdf

Comments are closed.

    Archives

    October 2023
    September 2023
    September 2022
    August 2022
    June 2022
    May 2022
    February 2022
    January 2022
    December 2021
    May 2021
    April 2021
    February 2021
    January 2021
    December 2020
    November 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    December 2019
    November 2019
    October 2019
    August 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    April 2015
    March 2015
    February 2015
    January 2015
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    February 2014
    January 2014
    December 2013
    October 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013

    RSS Feed

© The Vertical Group - [email protected]
 PO 218, Berkeley Heights, NJ 07922 | (908) 277-3737
PO 5006, San Mateo, CA  94402 | (650) 566-9060
Picture
Website by Custom Dynamics